Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy

Radiotherapy and Oncology

Volumn 80, Issue 3, 2006, Pages 378-384

  Meijer, Gert J ^a   van den Berg, Hetty A ^a   Hurkmans, Coen W ^a   Stijns, Pascal E ^b   Weterings, Jan H ^a  

^a Radiotherapy Department   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

125I; Brachytherapy; Dynamic dose calculation; Postimplant dosimetry; Prostate

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; DOSE CALCULATION; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE ANALYSIS; RADIATION DOSE; RECTUM; TIME SERIES ANALYSIS; TREATMENT PLANNING; URETHRA;

ALGORITHMS; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; NEEDLES; PROSTATIC NEOPLASMS; RADIOLOGY, INTERVENTIONAL; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; URETHRA;

EID: 33748880835     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.07.038     Document Type: Article

References (28)

1. Anderson L.L. A "natural" volume-dose histogram for brachytherapy. Med Phys 13 (1986) 898-903
2. Bice Jr. W.S., Prestidge B.R., Grimm P.D., et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 41 (1998) 921-927
3. Chauveinc L., Flam T., Solignac S., et al. Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group. Int J Radiat Oncol Biol Phys 59 (2004) 691-695
4. D'Souza W.D., Lee H.K., Palmer M.B., Smith L.G., and Pollack A. Is intraoperative nomogram-based overplanning of prostate implants necessary?. Int J Radiat Oncol Biol Phys 56 (2003) 462-467
5. Dogan N., Mohideen N., Glasgow G.P., Keys K., and Flanigan R.C. Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys 53 (2002) 483-489
6. Lee W.R., deGuzman A.F., Bare R.L., Marshall M.G., and McCullough D.L. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46 (2000) 83-88
7. Matzkin H., Kaver I., Bramante-Schreiber L., Agai R., Merimsky O., and Inbar M. Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators. Radiother Oncol 68 (2003) 289-294
8. McElveen T.L., Waterman F.M., Kim H., and Dicker A.P. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1395-1404
9. Moerland M.A., van der Laarse R., Luthmann R.W., Wijrdeman H.K., and Battermann J.J. The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants. Radiother Oncol 57 (2000) 279-284
10. Nag S., Bice W., DeWyngaert K., Prestidge B., Stock R., and Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
11. Nag S., Ciezki J.P., Cormack R., et al. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 51 (2001) 1422-1430
12. Nath R., Anderson L.L., Luxton G., Weaver K.A., Williamson J.F., and Meigooni A.S. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22 (1995) 209-234
13. Nath R., Roberts K., Ng M., Peschel R., and Chen Z. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys 25 (1998) 2293-2307
14. Raben A., Chen H., Grebler A., et al. Prostate seed implantation using 3 D-computer assisted intraoperative planning vs. a standard look-up nomogram: improved target conformality with reduction in urethral and rectal wall dose. Int J Radiat Oncol Biol Phys 60 (2004) 1631-1638
15. Reed D.R., Wallner K., Ford E., et al. Effect of post-implant edema on prostate brachytherapy treatment margins. Int J Radiat Oncol Biol Phys 63 (2005) 1469-1473
16. Roberson P.L., Narayana V., McShan D.L., Winfield R.J., and McLaughlin P.W. Source placement error for permanent implant of the prostate. Med Phys 24 (1997) 251-257
17. Salem N., Simonian-Sauve M., Rosello R., et al. Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study. Radiother Oncol 66 (2003) 159-165
18. Saw C.B., and Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 20 (1991) 135-139
19. Sidhu S., Morris W.J., Spadinger I., et al. Prostate brachytherapy postimplant dosimetry: a comparison of prostate quadrants. Int J Radiat Oncol Biol Phys 52 (2002) 544-552
20. Siebert F.A., Kohr P., and Kovacs G. The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm. Radiother Oncol 74 (2005) 169-175
21. Stock R.G., Stone N.N., Dahlal M., and Lo Y.C. What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. Brachytherapy 1 (2002) 83-89
22. Stock R.G., Stone N.N., Lo Y.C., Malhado N., Kao J., and DeWyngaert J.K. Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome. Int J Radiat Oncol Biol Phys 48 (2000) 899-906
23. Stock R.G., Stone N.N., Wesson M.F., and DeWyngaert J.K. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32 (1995) 219-225
24. Stone N.N., and Stock R.G. Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation. Tech Urol 1 (1995) 72-80
25. Tran A., Wallner K., Merrick G., et al. Rectal fistulas after prostate brachytherapy. Int J Radiat Oncol Biol Phys 63 (2005) 150-154
26. Van Gellekom M.P., Moerland M.A., Wijrdeman H.K., and Battermann J.J. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. Radiother Oncol 73 (2004) 49-56
27. Williams S.G., Millar J.L., Duchesne G.M., Dally M.J., Royce P.L., and Snow R.M. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy. Radiother Oncol 73 (2004) 33-38
28. Wust P., von Borczyskowski D.W., Henkel T., et al. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Radiother Oncol 73 (2004) 39-48